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Abstract
Lectin-binding studies were performed on rat pancreatic zymogen granules to investigate the alterations in the
carbohydrate membrane composition under both chronic CCK stimulation and long-term CCK blockade for 3, 7 and 15
days. By flow cytometry using FITC-WGA – which specifically binds to N-acetylglucosamine and sialic acid – we
measured the amount of WGA molecules bound to each individual granule. Parallel studies on pancreatic secretion were
 .also carried out. CCK treatment displayed a differential effect on two zymogen granule subpopulations Z and Z1 2
identified by flow cytometry on the basis of their light scatter properties: no effects on Z zymogen granules were observed2
in CCK-treated rats, while Z granules showed a significant increase in WGA binding at day q7 which coincides with an1
increase in protein secretion in response to the hormone. On the contrary, a significant decrease in the amount of WGA
receptors was observed in zymogen granule membrane of both the Z and Z subsets of rats subjected to a long-term CCK1 2
blockade. Again, these changes parallel to the reduction observed in protein secretion. Our results suggest that glycoconju-
gates of zymogen granule membrane involved in CCK-regulated exocytosis contain N-acetylglucosamine and sialic acid
residues whose quantities are regulated by CCK.
 .Keywords: Cholecystokinin; Exocrine pancreas; Glycoconjugate; Zymogen granule membrane; Rat
1. Introduction
Zymogen granules are important organella in the
secretory system of the exocrine pancreas, which are
involved in the enzyme packaging and secretion of
acinar cells. It has been reported that the protein
components of the zymogen granule membrane play
) Corresponding author. Fax: q34 23 294513. E-mail:
bel@gugu.usal.es
w xan important role in granule formation 1 . Moreover,
in response to appropriate stimuli, the exocrine pan-
creas secretes enzymes by exocytosis, a process that
involves the fusion of the zymogen granule mem-
brane with the apical plasma membrane of the acinar
cells. This phenomenon implies the recognition of the
two membranes and proteins are known to be in-
w xvolved in the process of membrane fusion 2–4 .
Intracellular mechanisms leading to secretion and the
structure and enzymatic activities of the digestive
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w xsecretory enzymes are well-established 5 . However,
comparatively little is known about the protein com-
ponents of the granule membrane despite their rele-
vant role in the secretion process.
Lectins are carbohydrate-binding compounds
which have been widely used to identify cell surface
w xglycoproteins and glycolipids 6–8 . Fracture-label
studies revealed lectin binding sites in the zymogen
granule membrane and a heterogenous population of
granules has been defined according to the lectin-
w xlabeling density 9 . Flow cytometry becomes a rapid,
objective, sensitive and quantitative method for the
analysis and quantification of large numbers of single
w xsubcellular components 10,11 , including the lectin
w xreceptors of zymogen granules in control rats 12 .
This work is focused to investigate how the glyco-
conjugates of the zymogen granule membrane of rat
pancreas are affected by two contrasting experimental
situations which have a clear influence on the exocy-
tosis phenomenon: long-term CCK and L-364,718 a
.CCK-receptor antagonist treatments. The aim of this
study is to know whether a relationship between
secretion of zymogen granules and their membrane
composition could be established.
2. Materials and methods
2.1. Products and companies
L-364,718, a CCK receptor antagonist, was kindly
 .donated by Merck Sharp and Dohme Madrid, Spain ,
 . Sucrose Merck , CCK-8 fragment 26-33 amide,
.  .99% purity , dimethylsulfoxide DMSO , Ethylene-
 . X Xglycol-bis- b-aminoethylether , N, N, N , N te-
 .  .traacetic acid EGTA , 3- N-morpholino propanesul-
 .fonic acid MOPS , phenyl-methylsulfonil fluoride
 .  .PMSF , 2- N-morpholino ethanesulfonic acid
 .MES , Percoll, FITC conjugated Triticum ˝ulgaris
 .  .lectin Wheat germ agglutinin FITC-WGA were
purchased from Sigma Chemical Co. St. Louis, MO,
.USA .
2.2. Animals and treatments
Male Wistar rats weighing about 250 g body weight
were used. Rats were fed ad libitum with standard
 .laboratory diet Panlab rat chow and had free access
to water. They were randomly separated into different
groups:
fl Controls
fl Rats treated with subcutaneous injections of CCK-
 .8 5 mgrkgr12 h for 3, 7 and 15 days
fl Rats treated with subcutaneous injections of L-
 .364,718 0.1 mgrkgrday in 10% DMSO as de-
pot carrier for 3, 7 and 15 days. A solution of 10%
DMSO was administered to rats in previous stud-
w xies 13,14 and no significant effect was observed
in pancreatic function.
Different animals were used to analyze zymogen
granules and pancreatic secretion.
Twelve hours after the last injection and while
fasting, the animals used to study zymogen granules
were killed by decapitation and their pancreases were
quickly removed and freed from fat and lymph nodes.
After 18 h fasting the animals used to study pancre-
atic secretion were surgically prepared for the collec-
tion of pancreatic juice as detailed below.
2.3. Isolation of zymogen granules
The pancreases from three animals were pooled
and put on ice-cold homogenization medium contain-
 .ing 250 mM sucrose, 5 mM MOPS pH 7.0 , 0.1 mM
MgSO and 0.1 mM PMSF at 40 mlrg wet weight4
pancreas. They were finely minced with scissors and
homogenized for 30 s in an electric homogenizer
 .Omni 2000 International at low speed. Heavy com-
ponents were removed by centrifugation at low speed.
Zymogen granules were isolated according to the
w xmethod of De Lisle et al. 15 by centrifuging at
100 000=g for 20 min in a 40% Percoll gradient
composed of a homogenization buffer, pH 5.5 250
mM sucrose, 50 mM MES, 0.1 mM MgSO , 0.1 mM4
.PMSF and 2 mM EGTA mixed with Percoll. Lastly,
 .the granules were washed twice 1300=g, 15 min
with a solution containing 0.3 M sucrose, 0.1 mM
 .Mg SO , 2 mM MOPS, 1 mM EGTA pH 6.5 .4
2.4. Staining of zymogen granules with FITC-WGA
Zymogen granules were incubated with lectin from
 .  .Triticum ˝ulgaris Wheat germ agglutinin WGA
 .conjugated with fluorescein isothiocyanate FITC at
 . w xsaturating concentration 1 mgrml 12 at 48C in the
dark for 45 min. The unbound FITC-WGA was
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removed by centrifugation twice in washing buffer
 .2=1300=g, 15 min, 48C . The specificity of the
binding of FITC-WGA to the zymogen granules was
assessed by using as a control the same concentration
of lectin but in the presence of N-acetyl glucosamine
w xas has been previously reported 12 .
2.5. Flow cytometric analysis of the zymogen gran-
ules
All flow cytometry measurements of zymogen
granules were performed for at least 10 000
eventsrtest of a pooled pancreas of five animals per
experiment. A FACScan flow cytometer
 .BectonrDickinson, San Jose, Ca, USA equipped
with an argon ion laser tuned at 488 nm and 15
w xmWatts was used, as previously described 12,16 .
 . Sample medium washing rsheath Facs flow, Bec-
.tonrDickinson differential pressure was set at low
speed in order to obtain a minimum diameter of the
sample part of the flow at the intersection of the laser
beam. During the whole measurement process the
zymogen granules remained resuspended in the wash-
ing buffer which is surrounded by the sheath fluid,
and no admixture between the two fluids occurs in
accordance with FACScan flow cytometer procedure
w x17 . Calibration of the instrument was performed on
a daily basis using CALIBRITE beads
 .BectonrDickinson . Fine adjustments were per-
formed using unstained zymogen granules. Each day
zymogen granules from control and CCK or L-
364,718-treated rats were measured in parallel. The
Lysis II software program was used for data acquisi-
tion and analysis. Results were expressed as the mean
value of at least six experiments, and in each experi-
ment the mean value per individual zymogen granule
was calculated using Lysis II software.
The amount of FITC-WGA bound to individual
zymogen granules was measured using molecule
 .equivalent soluble fluorescein MESF units. A mix-
ture of five different beads with well-established
amounts of FITC QuickCal beads, Flow Cytometry
.Standards Corporation was used to obtain a regres-
sion equation for each measurement that allowed the
calculation of the mean MESF content of zymogen
granules based on its mean fluorescence channels
 .scaled from 0 to 1023 channels arbitrary units . The
amount of lectin bound to each zymogen granule was
expressed as the number of molecules of lectin calcu-
lated from the ratio of the number of MESF for FITC
obtained per granule and the number of MESF for
FITC per one molecule of lectin.
2.6. Collection of pancreatic juice
Rats were anaesthetized with sodium pentobarbital
 .3 mgr100 g body weight, i.p. . After tracheotomy, a
median laparotomy was performed, the bile duct was
cannulated at its exit from the liver to divert bile flow
to the exterior and the pancreatic-bile duct was can-
nulated at its exit into the duodenum to collect pure
pancreatic juice. The animals were unconscious dur-
ing the entire juice collection period and body tem-
perature was kept at 37"168C by placing the rats on
a heating pad and monitoring rectal temperature with
a thermometer. Pancreatic juice was collected in
preweighed Eppendorf tubes on ice to preserve the
enzyme content. Total protein concentration in pan-
creatic juice was determined by the Bradford method
w x18 .
2.7. Statistical analysis
Results are expressed as means"S.E.M. Compar-
ative analysis between control and CCK-treated rats
and between control and L-364,718-treated rats were
 .made using the analysis of Variance ANOVA test
followed by the Scheffe test. An unpaired Student’s´
t-test was applied to the results obtained in the two
subpopulations of zymogen granules in each experi-
mental group. In all cases P-values lower than 0.05
were considered to be statistically significant.
3. Results
Fig. 1 shows a set of representative flow cytomet-
ric bivariate patterns of the isolated zymogen gran-
ules distributed according to their forward light scat-
 .  .ter FSC and their side light scatter SSC properties
 .from control rats Fig. 1A and according to the FSC
 .and WGA-FITC labelling Fig. 1C . Fig. 1B shows
and isotype-matched negative control. Each dot plot
is representative of one experiment.
On the basis of both parameters FSC and SSC, a
similar distribution of zymogen granules was ob-
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 .Fig. 1. Flow cytometric characterization of pancreatic Z and Z zymogen granules of the control rat pancreas log.rlog. representation .1 2
 .  .  .Forward scatter FSC rSide scatter SSC distribution pattern A ; FSCrfluorescence obtained for an isotype matched negative control
 .  .B ; FSCrWGA-FITC associated fluorescence C . Each dot plot is a representative example of one experiment.
served in controls, CCK- and L-364,718-treated rats.
Accordingly, two well-differentiated populations of
zymogen granules have been defined in all experi-
 .mental groups: a major population Z and a minor1
 .subset Z with larger and more complex granules2
than in Z .1
Fig. 2. Number of WGA molecules bound to each individual
 . zymogen granule of control rats ns12 , CCK-treated rats 5
.  .  .mgrkgr12 h for 3 days ns6 , 7 days ns5 and 15 days
 .  .ns6 and L-364,718 treated rats 0.1 mgrkgrday for 3 days
 .  .  .ns5 , 7 days ns6 and 15 days ns6 . n, number of
experiments. Values are means"S.E.M. Application of ANOVA
test followed by Scheffe test revealed significant differences with´
 .respect to controls ll P -0.01, lll P -0.001 , 3 days
 . CCK-treated rats ‘‘ P -0.01 and 15 days treated rats II
.P -0.01 .
The measurement of the mean number of WGA
molecules bound to each individual zymogen granule
 .belonging to both subpopulations Fig. 2 revealed a
 .significant increase P-0.001 in Z zymogen gran-1
ules from pancreas of rats treated with CCK for 7
days. However, CCK treatment did not display any
variation in the binding of FITC-WGA to Z zymo-2
gen granules. On the contrary, a significant decrease
in the number of WGA molecules bound to zymogen
granules from L-364,718-treated rats was observed in
both the Z and Z subsets at days q3 and q7 of1 2
the treatment. After fifteen days of L-364,718 treat-
ment a significant reduction of WGA receptors was
observed in Z zymogen granules but not in those1
belonging to the Z subset. In all animal groups a2
 . Fig. 3. Protein output in control rats ns11 , CCK-treated rats 5
.  .  .mgrkgr12 h for 3 days ns6 , 7 days ns6 and 15 days
 .  .ns6 and L-364,718-treated rats 0.1 mgrkgrday for 3 days
 .  .  .ns6 , 7 days ns7 and 15 days ns8 . n, number of
experiments. Values are means"S.E.M. Application of ANOVA
test followed by Scheffe test showed significant differences when´
 .compared with controls ll P -0.01, lllP -0.001 and
with 15 days CCK-treated rats II P -0.01, III P -
.0.001 .
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Table 1
 y2 .Comparative analysis of the number of WGA molecules =10 bound to Z and Z zymogen granules1 2
 .  .Controls CCK-8 5 mgrkgrday L-364,718 0.1 mgrkgrday
 .  .  .  .  .  .  .ns12 3 days ns6 7 days ns6 15 days ns6 3 days ns6 7 days ns6 15 days ns6
Z 389.7"35.6 570.5"31.0 1038.6"167.4 623.4"15.4 200.6"2.1 164.6"11.4 240.1"13.51
) ) ) ) ) ) )Z 1604.3"155.7 2065.7"258.9 1963.0"36.6 2192,1"91.1 867.1"26.3 739.2"113.4 1261.1"62.22
Values are expressed as means"S.E.M. nsnumber of experiments.
) .P-0.001 .
significant higher number of WGA molecules bounds
to Z zymogen granules than to those from Z subset2 1
 .Table 1 .
Fig. 3 shows the results observed in pancreatic
secretion. A progressively higher increase in protein
output was observed after 3 and 7 days of CCK
treatment but the secretion returned to control values
after 15 days. L-364,718 treatment displayed the
opposite effect since protein secretion decreased after
3 and 7 days, while at day q15 values close to those
of controls were reached.
4. Discussion
Previous studies have demonstrated that the pro-
tein composition of pancreatic zymogen granules of
different species is relatively simple, containing 8–10
w x w xmajor proteins 19–21 . Ronzio et al. 22 reported
that N-acetylglucosamine and sialic acid are impor-
tant carbohydrates in the composition of granule
membrane glycoproteins. The amount of these glu-
cidic radicals can be easily detected by labeling with
WGA, a lectin that specifically binds to them. Since
the content within zymogen granules from rat pan-
w xcreas fails to bind with WGA 7 , this lectin is useful
for analyzing the changes in the quantity of N-
acetylglucosamine and sialic acid in the membrane
that occur in response to stimuli such as CCK, which
is known to have effect on both the formation of new
w x w xgranules 23 and on exocytosis 24 , two processes
w xinvolving membrane glycoproteins 1–4 .
Despite the high content of N-acetylglucosamine
and sialic acid reported in pancreatic zymogen gran-
w xules 22 , no binding of WGA to the granule surface
w xhas been observed in previous studies 25 . Therefore,
the majority of N-acetylglucosamine and sialic acid
residues must be orientated towards the inside of the
zymogen granule. Intact zymogen granules allow the
w xpassage of protein across their membrane 26 and
previous studies on intact and permeabilized granules
have demonstrated that antisera which come up
against intragranular enzymes are able to cross the
membrane of non-permeabilized granules, showing a
higher fluorescence intensity in intact granules than
in permeabilized ones when incubated with FITC-
w xlectins 12 . Therefore FITC lectins can specifically
bind to carbohydrates of membrane glycoproteins
localized outside or inside zymogen granules.
w xRonzio’s work 22 reported three major glyco-
proteins as firmly bound constituents of zymogen
granule membrane: GP-1, GP-2 and GP-3. Of these,
GP-2 was shown to be the most abundant, accounting
for 40% of total zymogen granule membrane pro-
teins. Recently, a new glycoprotein identified as GP-4,
with similar molecular mass to that of GP-3 has been
purified from the zymogen granule membrane of pig
w x w xpancreas 27 and from human pancreatic juice 28 .
GP-1 is the only one exposed on the external face of
w xzymogen granules 22 . Although these glycoproteins
whave been characterized on the molecular level 27–
x30 their functions remain unclear. It has been as-
w xsumed that GP-2 has a role in granule formation 31 .
GP-3 is released into the pancreatic juice and its
secretion is strongly regulated by cholecystokinin
w x32 ; however, it has been suggested that this glyco-
protein is not part of the general exocytotic machin-
w xery 33 . GP-4 has demonstrated ATP-diphos-
w xphohydrolase activity 27 and it is released into
w xpancreatic juice 28 . Cytochemical studies have ob-
served ATP-diphosphohydrolase activity on the
plasma membrane of the acinar cells of rat pancreas
w x34 . Therefore it is likely that GP-4 is involved in the
fusion of mature zymogen granules with the acinar
cell membrane during exocytosis.
w xIn a similar fashion to that observed in control 12
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w xand adrenalectomized rats 16 , two different subsets
of zymogen granules are clearly identified in rats
subjected to long-term CCK and L-364,718 treat-
ments on the basis of FSC and SSC characteristics.
FSC is a parameter directly related to the cross-sec-
w xtioned area 35 , and therefore reflects the zymogen
granule size while SSC mainly reflects their internal
w xcomplexity 36 . Accordingly, Z zymogen granules1
are smaller and less complex which could be related
to the newer granules as has been suggested previ-
w xously 37 , while the Z zymogen granules could2
represent more mature granules formed as a result of
the fusion of granules that come into close contact
with each other. Moreover, significant differences in
the amount of amylase and trypsinogen stored in
zymogen granules have been found between Z and1
w xZ zymogen granules in rats treated with CCK 38 .2
Regarding the glycosylation of their membrane dif-
ferences between zymogen granules of both subsets
have also been observed in this study, the Z gran-2
ules displaying a significantly higher FITC-WGA
labelling than those of Z . This finding could have a1
physiological significance taking into account other
distinctive characteristics between both zymogen
granule subsets, in fact Z granules are bigger, more2
complex and have higher enzyme content than Z1
ones; thereby these seem to be the best prepared to
release the enzyme secretion by exocytosis. The high
degree of glycosylation that characterizes Z zymo-2
gen granules could be required in the step of recogni-
tion between the granule and acinar apical membrane
in the exocytosis process.
FITC-WGA labelling demonstrates a clear effect
of CCK on the composition of zymogen granule
membrane glycoconjugates. It is noteworthy that the
amount of sialic acid and N-acetylglucosamine signif-
icantly decreased when CCK was blocked by L-
364,718 the most specific CCK-receptor antagonist
w x.39 , and only increased when CCK exerted its
highest secretagogue effect, at day q7 of continuous
treatment. The return of WGA receptors to control
values observed at day q15 of CCK administration
coincides with a failure in CCK to stimulate pancre-
atic secretion. Both findings could be related to a
desensitization of the pancreas to long-term CCK
w xtreatment as has previously been reported 38,40 .
Since CCK stimulates the formation of new granules
and exocytosis, it would seem logical to suppose that
glycoconjugates involved in these functions would
increase in the zymogen granule membrane of rats
treated with CCK for 7 days. As such, our results
suggest that N-acetylglucosamine and sialic acid in-
creases could be related to these CCK regulated
functions. Moreover, long-term CCK administration
displayed a differential effect on Z and Z zymogen1 2
granules. Taking into account that only an increase in
WGA receptors was observed in granules belonging
to the Z subset – the newest granules –, but not in1
the Z zymogen granule subset, the finding could2
support the notion that N-acetylglucosamine and sialic
acid could be part of the composition of glyco-
proteins involved in zymogen granule formation.
On the other hand, the fact that the amount of
WGA molecules bound to the zymogen granule
membrane decreases in rats whose secretion is also
significantly reduced by the CCK-receptor antagonist
effect suggests that N-acetylglucosamine and sialic
acid could become a ‘label’ in the recognition step
between zymogen granule and the apical plasma
membranes in the exocytosis process. This hypothesis
would also be supported by the results observed in
CCK-treated rats in which the pattern of protein
secretion is similar to the changes in the amount of
WGA receptors in the membrane.
We cannot state with certainty which glycoconju-
gate is the most influenced by CCK levels but our
results suggest that some glycoprotein involved in the
secretion process would be the most likely candi-
dates. GP-3 is strongly regulated by cholecystokinin,
although its labelling with WGA-coupled horseradish
peroxidase on a Western blot system has been re-
w xported to be weak 32 . On the other hand, GP-4 is a
highly glycosylated protein with diphosphohydrolase
w xactivity 27 that has recently been associated with
secretory process. Since the hydrolysis of ATP could
provide energy required by the exocytosis, it could be
one of the glycoproteins influenced by the treatment.
Nor should the possibility of an alteration in the
glycosylation of glycoproteins in response to CCK
levels be discarded: i.e., the binding site may change
while the number of glycoproteins stays stable. In
any case, it is noteworthy that CCK exerts a direct
effect on the glucidic composition of the zymogen
granule membrane in rat pancreas and a correlation
between the amount of N-acetylglucosamine and sialic
acid and the pancreatic protein secretion can be estab-
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lished. Later studies should be carried out in order to
find out whether any specific glycoprotein or the
general glycosylation of zymogen granule membrane
is affected by CCK or its antagonist.
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